Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants

被引:6
作者
Bienvenu, A. L. [1 ,2 ]
Pradat, P. [3 ]
Matusik, E. [1 ]
Piriou, V. [4 ]
Rimmele, T. [5 ]
Parant, F. [6 ]
Tod, M. [1 ,7 ,8 ]
Leboucher, G. [1 ]
Goutelle, S. [1 ,7 ,8 ]
机构
[1] Hosp Civils Lyon, Serv Pharm, Grp Hosp Nord, Lyon, France
[2] Univ Lyon, ICBMS CNRS 5246, Campus Lyon Tech La Doua, Lyon, France
[3] Hosp Civils Lyon, Ctr Rech Clin, Grp Hosp Nord, Lyon, France
[4] Hosp Civils Lyon, Serv Anesthesie Reanimat, Grp Hosp Sud, Lyon, France
[5] Hosp Civils Lyon, Grp Hosp Ctr, Serv Anesthesie Reanimat, Lyon, France
[6] Hosp Civils Lyon, Lab Biochim & Biol Mol, UM Pharmacotoxicol Grp Hosp Sud, Lyon, France
[7] Univ Lyon 1, Univ Lyon, Fac Pharm Lyon, ISPB, Lyon, France
[8] Univ Lyon 1, Univ Lyon, CNRS, UMR 5558,Lab Biometrie & Biol Evolut, Villeurbanne, France
来源
INFECTIOUS DISEASES NOW | 2023年 / 53卷 / 02期
关键词
Antifungal stewardship; Critically ill patients; Fluconazole; Pharmacokinetic; Therapeutic drug monitoring;
D O I
10.1016/j.idnow.2022.10.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study aims at evaluating fluconazole exposure in critically ill patients and identifying variables associated with the latter.Patients and methods: This was a 2-year (2018-2019) retrospective multicenter cohort study. Adult patients > 18 years-old with at least one fluconazole concentration measurement during their ICU stay were included.Results: Twenty patients were included. Only 11 patients had a fluconazole trough concentration (Cmin) within the target range (>= 15 mg/L). According to bivariable analysis, SOFA score, GGT, fluconazole clear-ance, Ke, and Vd, were independently associated with a decrease in fluconazole Cmin. The median loading dose required to achieve the Cmin target appeared to be greater in patients with higher SOFA or GGT level and in patients undergoing renal replacement therapy.Conclusions: This study supports recommendation for routine fluconazole therapeutic drug monitoring in ICU patients so as to avoid underexposure, especially if SOFA score is >= 7 and/or GGT is >= 100 U/L.
引用
收藏
页数:4
相关论文
共 10 条
  • [1] Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
    Abdul-Aziz, Mohd H.
    Alffenaar, Jan-Willem C.
    Bassetti, Matteo
    Bracht, Hendrik
    Dimopoulos, George
    Marriott, Deborah
    Neely, Michael N.
    Paiva, Jose-Artur
    Pea, Federico
    Sjovall, Fredrik
    Timsit, Jean F.
    Udy, Andrew A.
    Wicha, Sebastian G.
    Zeitlinger, Markus
    De Waele, Jan J.
    Roberts, Jason A.
    [J]. INTENSIVE CARE MEDICINE, 2020, 46 (06) : 1127 - 1153
  • [2] Intensive care medicine research agenda on invasive fungal infection in critically ill patients
    Bassetti, Matteo
    Garnacho-Montero, Jose
    Calandra, Thierry
    Kullberg, Bartjan
    Dimopoulos, George
    Azoulay, Elie
    Chakrabarti, Arunaloke
    Kett, Daniel
    Leon, Cristobal
    Ostrosky-Zeichner, Luis
    Sanguinetti, Maurizio
    Timsit, Jean-Francois
    Richardson, Malcom D.
    Shorr, Andrew
    Cornely, Oliver A.
    [J]. INTENSIVE CARE MEDICINE, 2017, 43 (09) : 1225 - 1238
  • [3] A systematic review of interventions and performance measures for antifungal stewardship programmes
    Bienvenu, A. L.
    Argaud, L.
    Aubrun, F.
    Fellahi, J. L.
    Guerin, C.
    Javouhey, E.
    Piriou, V.
    Rimmele, T.
    Chidiac, C.
    Leboucher, G.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (02) : 297 - 305
  • [4] Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis
    Bienvenu, Anne-Lise
    Pradat, Pierre
    Guerin, Claude
    Aubrun, Frederic
    Fellahi, Jean-Luc
    Friggeri, Arnaud
    Guichon, Celine
    Hernu, Romain
    Menotti, Jean
    Monard, Celine
    Paulus, Sylvie
    Rimmele, Thomas
    Piriou, Vincent
    Chidiac, Christian
    Argaud, Laurent
    Leboucher, Gilles
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 93 : 15 - 21
  • [5] Boonstra JM, 2020, ANTIMICROB AGENTS CH
  • [6] Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
    Leroy, Olivier
    Bailly, Sebastien
    Gangneux, Jean-Pierre
    Mira, Jean-Paul
    Devos, Patrick
    Dupont, Herve
    Montravers, Philippe
    Perrigault, Pierre-Francois
    Constantin, Jean-Michel
    Guillemot, Didier
    Azoulay, Elie
    Lortholary, Olivier
    Bensoussan, Caroline
    Timsit, Jean-Francois
    [J]. ANNALS OF INTENSIVE CARE, 2016, 6 : 1 - 11
  • [7] Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
    Sinnollareddy, Mahipal G.
    Roberts, Jason A.
    Lipman, Jeffrey
    Akova, Murat
    Bassetti, Matteo
    De Waele, Jan J.
    Kaukonen, Kirsi-Maija
    Koulenti, Despoina
    Martin, Claude
    Montravers, Philippe
    Rello, Jordi
    Rhodes, Andrew
    Starr, Therese
    Wallis, Steven C.
    Dimopoulos, George
    [J]. CRITICAL CARE, 2015, 19
  • [8] Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
    Soulountsi, Vasiliki
    Schizodimos, Theodoros
    Kotoulas, Serafeim Chrysovalantis
    [J]. INFECTION, 2021, 49 (06) : 1107 - 1131
  • [9] Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients
    Van Daele, Ruth
    Wauters, Joost
    Lagrou, Katrien
    Denooz, Raphael
    Hayette, Marie-Pierre
    Gijsen, Matthias
    Brueggemann, Roger J.
    Debaveye, Yves
    Spriet, Isabel
    [J]. MICROORGANISMS, 2021, 9 (10)
  • [10] Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
    Vena, Antonio
    Munoz, Patricia
    Mateos, Miriam
    Guinea, Jesus
    Galar, Alicia
    Pea, Federico
    Alvarez-Uria, Ana
    Escribano, Pilar
    Bouza, Emilio
    [J]. INFECTIOUS DISEASES AND THERAPY, 2020, 9 (01) : 137 - 149